Halaman 4 - Hematologi Onkologi hematolog-onkologis Terbaik - TOP-171 dokter

Spesialisasi dalam transplantasi sel induk autolog dan alogenik untuk leukemia dan limfoma di Valued Med Hub Hospitals.

• Associate Professor dengan pengalaman luas di bidang hematologi
• Ahli dalam menangani leukemia akut dan kronis, termasuk AML dan ALL
• Fokus pada limfoma Hodgkin dan non-Hodgkin
• Menempuh pendidikan di Rumah Sakit Pelatihan dan Penelitian Onkologi Ankara – pusat hematologi terkemuka

Dr. Carmen Martínez Chamorro mengkhususkan diri dalam transplantasi sumsum tulang dewasa untuk leukemia, limfoma, dan myeloma di Quironsalud Madrid.

• Wakil Kepala Hematologi di Quironsalud Madrid
• Penulis 20 artikel medis dan peserta dalam 60 konferensi
• Menempuh pendidikan di Rumah Sakit Universitas La Princesa di Madrid
• Penerima Penghargaan Nasional untuk Penelitian di Bidang Bedah

Profesor Drach telah melakukan 1.100+ prosedur onkologi dan memimpin program Mieloma Multipel dan Limfoma Malignan di Rumah Sakit Universitas Wina – salah satu yang terbesar di Eropa.

• Spesialisasi dalam onkologi hematologi dengan pengalaman 25+ tahun
• Mantan dokter kepala di Rumah Sakit Universitas Kedokteran Penyakit Dalam I Wina
• Menerbitkan 120+ makalah ilmiah tentang hematologi dan onkologi
• Anggota dewan Masyarakat Hematologi dan Onkologi Austria
• Menawarkan opini kedua dan optimalisasi terapi pra-bedah

Profesor Hasan Atilla Ozkan memimpin Asosiasi Aferesis Terapeutik Turki dan berspesialisasi dalam transplantasi sel punca di Rumah Sakit VM Medical Park Pendik.

• Pengalaman 20+ tahun dalam bidang hematologi dan transplantasi sumsum tulang
• Tersertifikasi dalam transplantasi sel punca autolog dan alogenik oleh EBMT
• Profesor aktif di Fakultas Kedokteran Universitas Yeditepe
• Penerima Penghargaan Peneliti Muda dalam Aferesis Terapeutik

Assoc. Prof. Dr. Özlem Köroğlu is a specialist in Physical Medicine and Rehabilitation at Memorial Ankara Hospital (2024–present). She previously served as a faculty member at Gaziler Physical Therapy and Rehabilitation Training and Research Hospital (2016–2024). She was Chief of the Physical Medicine and Rehabilitation Clinic at Elazığ Military Hospital (2011–2015). She earned her MD in 2003 from the GATA Faculty of Medicine. She completed her PM&R residency in 2011.

Her credentials include Ministry of Health–approved certified prolotherapy training. She has taught Prolotherapy and PRP (2022) and Knee Prolotherapy and Campinject (2019). She also taught GETAT and Dextrose Prolotherapy (2018) and ISPRM Ultrasound (2009). She has additional training in musculoskeletal ultrasound, neural therapy, lumbar injections and manipulation, and botulinum toxin treatment for the spastic hand. She attended the Euro‑Mediterranean PRM School in Italy (2010). She is a member of the Turkish Society of PM&R, the Turkish Society for Research and Fight Against Rheumatism, the Association of PM&R Specialists of Türkiye, the Spinal Cord Diseases Association, and the Ankara Medical Chamber.

Dr. Osman Ilhan is a Professor of Internal Diseases. He earned his medical degree at Ankara University in 1978. He completed his specialization in Internal Diseases there in 1982. He became an Associate Professor in 1990 and a Professor in 1996.

He served as a professor at Ankara University from 1997 to 2022. He has worked at Lokman Hekim Akay Hospital since 2023. Earlier, he held roles at MD Anderson Cancer Center (1996–1997), Ankara University (1978–1983; 1988–1995), GATA (1984–1985), and Ulus Hospital (1985–1988).

1.100+ prosedur limfoma dilakukan – Prof. Weidmann memimpin Hematologi di Klinik Nordwest, pusat terkemuka untuk gangguan darah.

• Spesialisasi dalam perawatan limfoma Hodgkin dan non-Hodgkin
• Profesor dengan keahlian akademik dan klinis yang luas
• 30+ tahun fokus pada perawatan gangguan darah
• Memimpin salah satu departemen hematologi top di Jerman

Terdaftar di Forbes sebagai salah satu dokter terbaik Israel – Dr. Goldstein memimpin Onkologi Anak di Hadassah Medical Center.

• Spesialisasi dalam hemato-onkologi anak selama lebih dari 20 tahun
• Ahli dalam retinoblastoma dan pendekatan kedokteran presisi
• Melakukan transplantasi sumsum tulang haploidentik untuk anak-anak
• Anggota dari empat asosiasi onkologi anak internasional

Prof. Reuven Or memimpin Departemen Hematologi dan Transplantasi Sumsum Tulang di Hadassah – pelopor dalam imunoterapi kanker dan terapi sel.

• 15+ tahun spesialisasi dalam transplantasi sumsum tulang dan kanker hematologi
• Direktur Medis Bank Darah Nasional Israel dan Registri Sumsum Tulang Publik
• Penerima Penghargaan Menachem Begin yang bergengsi untuk pencapaian medis
• Terlatih di institusi papan atas di Italia dan AS
• Menerbitkan beberapa artikel penelitian di jurnal medis

Spesialisasi dalam kanker hematologi dan transplantasi sumsum tulang tingkat lanjut – Dr. Alemdar memadukan keunggulan akademik di Universitas Akdeniz dengan 15+ tahun praktik klinis.

• Bersertifikat dewan dalam Onkologi Medis dengan pelatihan Kedokteran Internal tambahan
• Pakar dalam terapi sel CAR-T dan transplantasi sel punca haploidentik
• Anggota Asosiasi Onkologi Medis Turki
• Bekerja di Kompleks Rumah Sakit Medical Park Antalya yang terakreditasi JCI

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

 Mali interdisciplinary hospital is integrating conventional, regenerative and precision medicine. It divides into 11 departments, there are 35 beds in total, including 12 intensive care beds, 23 general beds, 2 emergency and operating rooms, 1 plastic surgical room, 1 Gastro-colonoscopic room. Focus on round-trip treatment with modern medical technology to reduce the cost of hospitalization and the healing time. It also integrating regenerative medicine to repair the body and precision medicine for preventing and treating chronic non-communicable diseases (NCDs) with better results, we provide these services in a greenery atmosphere. Allowing clients to receive the following benefits.

1. Far away from NCDs & It’s complication

2. Good quality of life

3. Youthful lively life

4. Longevity

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.